ImmTune Therapies
Cell and Gene
ImmTune Therapies is developing gene delivery vectors for specific modification of immune cells inside a patient’s body. Their ambition is to enable an in vivo cell therapy process, whereby an injection of their product generates a dose of therapeutic cells, such as CAR-Ts, within the body.
See other Cell and Gene organisations
-
Achilles Therapeutics is a biopharmaceutical company developing personalised T cell therapies targeting clonal neoantigens: protein markers unique to the individual ... -
Aglaris Ltd produce equipment to ensure cell and tissue culture is an easy, problem-free task. -
Autolus is founded on advanced cell programming technology pioneered by Dr Martin Pule and was spun-out from University College London ... -
The Cell and Gene Therapy Catapult was established in 2012 as an independent centre of excellence to advance…
Stevenage Bioscience Catalyst is the UK's leading open innovation campus with a focus on therapeutics.
Learn moreCopyright © 2023 Stevenage Bioscience Catalyst
We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.